Pharmaceutical

Aspect wins $72.75m from Canadian government for bioprinted pipeline

Novo Nordisk-partnered Aspect develops bioprinted tissue therapeutics designed to replace or support specific biological functions.

Jul 12, 2024 - 04:00
Aspect wins $72.75m from Canadian government for bioprinted pipeline
Novo Nordisk-partnered Aspect develops bioprinted tissue therapeutics designed to replace or support specific biological functions.
Read the original article

Tags:

Previous Article

Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%

Next Article

After AdCom rejection, FDA rebuffs Novo Nordisk’s once-weekly insulin

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: ‘Shocking’ heat waves persist through August as federal officials warn of far-ranging health risks

STAT+: ‘Shocking’ heat waves persist through August as ...

Aug 7, 2023

Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease

Eli Lilly’s donanemab wins FDA approval for Alzheimer’s...

Jul 4, 2024

STAT+: A young boy’s nightmare diagnosis, and the $3 million one-time treatment that will likely save his life

STAT+: A young boy’s nightmare diagnosis, and the $3 mi...

Apr 3, 2023